OMass Therapeutics Takes on ‘Undruggable’ Proteins with €90M Series B
The UK firm OMass Therapeutics has unveiled a €90M (£75.5M) Series B financing to bankroll…
28/04/2022 - 3 minutes
Inflammatory disease
Epidarex Backs UK Startup Developing Emerging Anti-Inflammatory Drugs
The UK-US venture capitalist Epidarex Capital has led an €11M (£9M) funding round raised by…
08/04/2022 - 3 minutes
Targeted Drugs for Rare Autoimmune Disease Hit Regulatory Milestones
New, more targeted treatments are on the horizon for the rare autoimmune disease ANCA-associated vasculitis,…
01/12/2021 - 4 minutes
The Rollercoaster of Repurposing an Arthritis Drug for Covid-19
The Covid-19 pandemic created an opportunity for many biotech companies to repurpose their existing programs…
10/05/2021 - 8 minutes
Galapagos’ Arthritis Drug Approved in EU and Japan Amid US Rejection
The recent EU and Japan approvals of the rheumatoid arthritis drug filgotinib contrast with the…
05/10/2020 - 5 minutes
Roche Confirms Pharma Appetite for Inflammatory Disease Treatments
Roche’s acquisition of the Irish biotech Inflazome is a vote of confidence for emerging inflammatory…
25/09/2020 - 4 minutes
€18M to Fund First-in-Class Systemic Sclerosis Drug
One of the largest biotech placements in the Nordic countries this year will accelerate the…
09/07/2020 - 2 minutes
Boost For Inflammatory Disease Biotech NodThera With €49M Series B
The UK-US biotech NodThera has raised €48.7M in Series B funding to progress its drug…
06/06/2020 - 3 minutes
Rare Inflammatory Disease Drug Beats Immunosuppressants in Phase III
A small molecule drug developed by the US company ChemoCentryx and its Swiss partner Vifor…
26/11/2019 - 3 minutes
Update: Abivax’s Ulcerative Colitis Drug Effective Long-Term
Update (21/10/2019): An extension of French biotech Abivax’s phase IIa trial shows its treatment for…
21/10/2019 - 2 minutes
French Biotech to Develop Septic Shock Therapy with €39M Series B
The French company Inotrem has raised €39M to fund an immunotherapy for septic shock, an…
12/09/2019 - 3 minutes
Swedish Ulcerative Colitis Treatment Makes Phase II Comeback
InDex Pharmaceuticals’ ulcerative colitis drug candidate has achieved positive phase IIb results, suggesting work to…
27/08/2019 - 2 minutes
